Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	2023	2022	2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.36	2.14	0.06	0.65
Cash & Short-Term Investments	0.36	2.14	0.06	0.65
Cash Growth	517.24%	3594.83%	-91.12%	-
Other Receivables	0.08	0.08	0.02	0.04
Receivables	0.08	0.08	0.02	0.04
Prepaid Expenses	0.06	0.03	0.01	0.01
Total Current Assets	0.5	2.26	0.08	0.7
Property, Plant & Equipment	0.06	-	-	0.19
Other Intangible Assets	0.63	0.39	-	0
Other Long-Term Assets	-	-	0.05	0.06
Total Assets	1.2	2.64	0.14	0.95
Accounts Payable	1.27	0.46	0.42	0.5
Accrued Expenses	0.97	1.9	0.74	0.75
Short-Term Debt	0.18	0.18	0.18	2.26
Current Unearned Revenue	-	-	0.91	0.46
Total Current Liabilities	2.41	2.53	2.25	3.97
Total Liabilities	2.41	2.53	2.25	3.97
Common Stock	-	-	0.02	-
Additional Paid-In Capital	77.8	76.73	71.78	61.89
Retained Earnings	-79.01	-76.62	-73.91	-67.33
Total Common Equity	-1.22	0.11	-2.11	-5.44
Shareholders' Equity	-1.22	0.11	-2.11	-3.01
Total Liabilities & Equity	1.2	2.64	0.14	0.95
Total Debt	0.18	0.18	0.18	2.26
Net Cash (Debt)	0.18	1.97	-0.12	-1.6
Net Cash Per Share	0.00	0.06	-0.05	-
Filing Date Shares Outstanding	7.87	35.37	2.55	-
Total Common Shares Outstanding	49.95	35.37	2.55	-
Working Capital	-1.91	-0.28	-2.16	-3.26
Book Value Per Share	-0.02	0.00	-0.83	-
Tangible Book Value	-1.85	-0.28	-2.11	-5.44
Tangible Book Value Per Share	-0.04	-0.01	-0.83	-
Machinery	0.06	-	3.22	3.98

Source: S&P Capital IQ. Standard template. Financial Sources.